Save time and get answers to complex questions with AI chat
Drug patent watch trametinib?When will there be a generic loreev available?Somatuline depot patent expiry date?Pramlintide fda approval date?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for bosulif
Bosulif is a brand name (often written as “Bosulif” in prescriptions). The generic name is bosutinib (marketed as bosutinib tablets).
If you mean the FDA’s list of generic names (or typical “generic name” listings used by pharmacies), Bosulif would appear there under bosutinib, not as “Bosulif.”
In standard drug naming, Bosulif is not the generic name. It is the branded product name, while bosutinib is the active ingredient name used as the generic name.
Other Questions About Bosulif :